https://www.amgen.com/newsroom/press-releases/2014/01/romosozumab-phase-2-data-published-in-new-england-journal-of-medicine-show-significant-increases-in-bone-mineral-density-at-both-spine-and-hip
Romosozumab Phase 2 Data Published In New England Journal Of Medicine Show Significant Increases In...
https://pmc.ncbi.nlm.nih.gov/articles/PMC13090615/
Romosozumab Versus Teriparatide for the Treatment of Postmenopausal Osteoporosis: An Overview of...
To summarize the evidence of efficacy and safety of romosozumab compared to teriparatide for postmenopausal osteoporosis. A literature search was performed in...
for thepostmenopausal osteoporosisromosozumabversusteriparatide
https://www.sciencedaily.com/releases/2014/06/140611093711.htm
Romosozumab significantly increases bone mineral density and bone content compared with...
A new study shows that in postmenopausal women with low bone mass, romosozumab significantly increased bone mineral density and bone content in both the spine...
bone mineral densityromosozumabsignificantlyincreasescontent
https://rheumatology.org/patients/romosozumab-evenity
Romosozumab (Evenity) | American College of Rheumatology
Facts for patients and caregivers about the drug Romosozumab (Evenity) such as how it works, common dosages, safety tips, and possible side effects.
american collegeromosozumabevenityrheumatology